[HTML][HTML] Regulation of dual-specificity phosphatase (DUSP) ubiquitination and protein stability
HF Chen, HC Chuang, TH Tan - International journal of molecular …, 2019 - mdpi.com
Mitogen-activated protein kinases (MAPKs) are key regulators of signal transduction and cell
responses. Abnormalities in MAPKs are associated with multiple diseases. Dual-specificity …
responses. Abnormalities in MAPKs are associated with multiple diseases. Dual-specificity …
Molecular pathways: targeting protein tyrosine phosphatases in cancer
LR Bollu, A Mazumdar, MI Savage, PH Brown - Clinical Cancer Research, 2017 - AACR
The aberrant activation of oncogenic signaling pathways is a universal phenomenon in
cancer and drives tumorigenesis and malignant transformation. This abnormal activation of …
cancer and drives tumorigenesis and malignant transformation. This abnormal activation of …
[HTML][HTML] Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression
K Chen, Q Wang, M Li, H Guo, W Liu, F Wang, X Tian… - …, 2021 - thelancet.com
Background Pancreatic ductal adenocarcinoma (PDAC) is most aggressive among all
gastrointestinal tumors. The complex intra-tumor heterogeneity and special tumor …
gastrointestinal tumors. The complex intra-tumor heterogeneity and special tumor …
[HTML][HTML] CRISPR screens identify gene targets at breast cancer risk loci
Background Genome-wide association studies (GWAS) have identified> 200 loci associated
with breast cancer risk. The majority of candidate causal variants are in non-coding regions …
with breast cancer risk. The majority of candidate causal variants are in non-coding regions …
Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification
B Meeusen, V Janssens - The international journal of biochemistry & cell …, 2018 - Elsevier
Aberrant protein phosphorylation is one of the hallmarks of cancer cells, and in many cases
a prerequisite to sustain tumor development and progression. Like protein kinases, protein …
a prerequisite to sustain tumor development and progression. Like protein kinases, protein …
The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer
PP Gao, XW Qi, N Sun, YY Sun, Y Zhang… - … et Biophysica Acta (BBA …, 2021 - Elsevier
Reversible phosphorylation of proteins, controlled by kinases and phosphatases, is involved
in various cellular processes. Dual-specificity phosphatases (DUSPs) can dephosphorylate …
in various cellular processes. Dual-specificity phosphatases (DUSPs) can dephosphorylate …
IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition
The tumor microenvironment supplies proinflammatory cytokines favoring a permissive
milieu for cancer cell growth and invasive behavior. Here we show how breast cancer …
milieu for cancer cell growth and invasive behavior. Here we show how breast cancer …
[HTML][HTML] Germline stem cell activity is sustained by SALL4-dependent silencing of distinct tumor suppressor genes
AL Chan, HM La, JMD Legrand, JA Mäkelä… - Stem Cell Reports, 2017 - cell.com
Sustained spermatogenesis in adult males and fertility recovery following germ cell
depletion are dependent on undifferentiated spermatogonia. We previously demonstrated a …
depletion are dependent on undifferentiated spermatogonia. We previously demonstrated a …
Concurrent HER or PI3K inhibition potentiates the antitumor effect of the ERK inhibitor ulixertinib in preclinical pancreatic cancer models
H Jiang, M Xu, L Li, P Grierson, P Dodhiawala… - Molecular cancer …, 2018 - AACR
Effective treatment for pancreatic ductal adenocarcinoma (PDAC) is an urgent, unmet
medical need. Targeting KRAS, the oncogene that is present in> 95% of PDAC, is a heavily …
medical need. Targeting KRAS, the oncogene that is present in> 95% of PDAC, is a heavily …
[HTML][HTML] DUSP4 promotes esophageal squamous cell carcinoma progression by dephosphorylating HSP90β
L Zhou, N Yao, L Yang, K Liu, Y Qiao, C Huang, R Du… - Cell Reports, 2023 - cell.com
The molecular and pathogenic mechanisms of esophageal squamous cell carcinoma
(ESCC) development are still unclear, which hinders the development of effective …
(ESCC) development are still unclear, which hinders the development of effective …